Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 232

1.

Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.

Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R; Israeli Bacteremia and Meningitis Active Surveillance Group.

Vaccine. 2012 Oct 12;30(46):6600-7. doi: 10.1016/j.vaccine.2012.08.012. Epub 2012 Aug 30.

PMID:
22939907
[PubMed - indexed for MEDLINE]
2.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490
[PubMed - indexed for MEDLINE]
3.

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance.

Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S, Miron D, Dagan R.

Vaccine. 2014 Jun 5;32(27):3452-9. doi: 10.1016/j.vaccine.2014.03.065. Epub 2014 Mar 30.

PMID:
24690148
[PubMed - indexed for MEDLINE]
4.

Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.

Yildirim I, Stevenson A, Hsu KK, Pelton SI.

Pediatr Infect Dis J. 2012 Oct;31(10):1016-21. doi: 10.1097/INF.0b013e3182615615.

PMID:
22673142
[PubMed - indexed for MEDLINE]
5.

Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).

Shibl AM, Memish ZA, Al-Kattan KM.

Vaccine. 2012 Dec 31;30 Suppl 6:G32-6. doi: 10.1016/j.vaccine.2012.07.030.

PMID:
23228355
[PubMed - indexed for MEDLINE]
6.

Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.

Mokaddas E, Albert MJ.

Vaccine. 2012 Dec 31;30 Suppl 6:G37-40. doi: 10.1016/j.vaccine.2012.10.061.

PMID:
23228356
[PubMed - indexed for MEDLINE]
7.

Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark.

Harboe ZB, Valentiner-Branth P, Ingels H, Rasmussen JN, Andersen PH, Bjerre CC, Goldblatt D, Ashton L, Haston M, Konradsen HB, Lambertsen L; Danish Pneumococcal Surveillance Collaborating Group.

PLoS One. 2013;8(1):e51460. doi: 10.1371/journal.pone.0051460. Epub 2013 Jan 24.

PMID:
23365635
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.

Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R.

Pediatr Infect Dis J. 2009 Apr;28(4):277-82. doi: 10.1097/INF.0b013e31818e0e2e.

PMID:
19258924
[PubMed - indexed for MEDLINE]
9.

Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.

Elberse KE, van der Heide HG, Witteveen S, van de Pol I, Schot CS, van der Ende A, Berbers GA, Schouls LM.

Vaccine. 2012 Dec 14;30(52):7644-51. doi: 10.1016/j.vaccine.2012.04.021. Epub 2012 Apr 19.

PMID:
22521844
[PubMed - indexed for MEDLINE]
10.

Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.

Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, Konradsen H, Hoffmann S, Valentiner-Branth P, Lambertsen L; Danish Pneumococcal Surveillance Collaboration Group 2009-2010.

Vaccine. 2012 Jun 6;30(26):3944-50. doi: 10.1016/j.vaccine.2012.03.060. Epub 2012 Apr 11.

PMID:
22504662
[PubMed - indexed for MEDLINE]
11.

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.

Isaacman DJ, McIntosh ED, Reinert RR.

Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22. Review.

PMID:
19700359
[PubMed - indexed for MEDLINE]
Free Article
12.

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.

Pediatr Infect Dis J. 2007 Sep;26(9):771-7.

PMID:
17721369
[PubMed - indexed for MEDLINE]
13.

Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.

Hsu KK, Shea KM, Stevenson AE, Pelton SI; Massachusetts Department of Public Health.

Pediatr Infect Dis J. 2010 Apr;29(4):289-93. doi: 10.1097/INF.0b013e3181c15471.

PMID:
19935447
[PubMed - indexed for MEDLINE]
14.

Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.

van der Linden M, Weiß S, Falkenhorst G, Siedler A, Imöhl M, von Kries R.

Vaccine. 2012 Aug 31;30(40):5880-5. doi: 10.1016/j.vaccine.2012.06.068. Epub 2012 Jul 4.

PMID:
22771186
[PubMed - indexed for MEDLINE]
15.

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.

Albrich WC, Baughman W, Schmotzer B, Farley MM.

Clin Infect Dis. 2007 Jun 15;44(12):1569-76. Epub 2007 May 8.

PMID:
17516400
[PubMed - indexed for MEDLINE]
Free Article
16.

Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).

American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2010 Jul;126(1):186-90. doi: 10.1542/peds.2010-1280. Epub 2010 May 24.

PMID:
20498180
[PubMed - indexed for MEDLINE]
Free Article
17.

Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.

Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, Byington CL.

Pediatrics. 2013 Jul;132(1):e17-24. doi: 10.1542/peds.2012-3900. Epub 2013 Jun 3.

PMID:
23733800
[PubMed - indexed for MEDLINE]
Free PMC Article
18.
19.

The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.

Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL.

Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72.

PMID:
22330164
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.

Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G; Lebanese Inter-Hospital Pneumococcal Surveillance Program.

Vaccine. 2012 Dec 31;30 Suppl 6:G11-7. doi: 10.1016/j.vaccine.2012.07.020.

PMID:
23228352
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk